Nicolas Calo

582 total citations
13 papers, 433 citations indexed

About

Nicolas Calo is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Nicolas Calo has authored 13 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Nicolas Calo's work include Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Nicolas Calo is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). Nicolas Calo collaborates with scholars based in Switzerland, United States and India. Nicolas Calo's co-authors include Michelangelo Foti, Cyril Sobolewski, Jean‐François Dufour, Bostjan Humar, Margot Fournier, Christine Maeder, Céline Lamacchia, Dominique Talabot‐Ayer, Gaby Palmer and Cem Gabay and has published in prestigious journals such as Nature Communications, Hepatology and Annals of Surgery.

In The Last Decade

Nicolas Calo

12 papers receiving 429 citations

Peers

Nicolas Calo
Nicolas Calo
Citations per year, relative to Nicolas Calo Nicolas Calo (= 1×) peers Karina Kreggenwinkel

Countries citing papers authored by Nicolas Calo

Since Specialization
Citations

This map shows the geographic impact of Nicolas Calo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Calo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Calo more than expected).

Fields of papers citing papers by Nicolas Calo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Calo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Calo. The network helps show where Nicolas Calo may publish in the future.

Co-authorship network of co-authors of Nicolas Calo

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Calo. A scholar is included among the top collaborators of Nicolas Calo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Calo. Nicolas Calo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dawson, John R.D., Nicolas Calo, Kalyana Bharati Akondi, et al.. (2025). Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping. Nature Communications. 16(1). 7695–7695.
2.
Calo, Nicolas, et al.. (2024). Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions. Scientific Reports. 14(1). 292–292. 3 indexed citations
3.
Gjorgjieva, Monika, Nicolas Calo, Cyril Sobolewski, et al.. (2024). Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver. JHEP Reports. 7(4). 101305–101305. 4 indexed citations
4.
Tsai, Ching‐Ju, Filip Pamula, Kenneth N. Goldie, et al.. (2021). Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist. Science Advances. 7(25). 46 indexed citations
5.
Sousa, Marta Correia de, Nicolas Calo, Cyril Sobolewski, et al.. (2021). Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers. 13(19). 4983–4983. 24 indexed citations
6.
Sobolewski, Cyril, Daniel Abegg, Flavien Berthou, et al.. (2020). S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut. 69(10). 1841–1854. 62 indexed citations
7.
Clément, Sophie, Cyril Sobolewski, Ángela Rojas, et al.. (2019). Activation of the oncogenic miR‐21‐5p promotes HCV replication and steatosis induced by the viral core 3a protein. Liver International. 39(7). 1226–1236. 27 indexed citations
8.
Linecker, Michael, Lukas Frick, Philipp Kron, et al.. (2018). Exercise Improves Outcomes of Surgery on Fatty Liver in Mice. Annals of Surgery. 271(2). 347–355. 10 indexed citations
9.
Tschuor, Christoph, Nicolas Calo, U. Ungethüm, et al.. (2017). PTEN Down‐Regulation Promotes β‐Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice. Hepatology. 66(3). 908–921. 48 indexed citations
10.
Calo, Nicolas, Pierluigi Ramadori, Cyril Sobolewski, et al.. (2016). Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut. 65(11). 1871–1881. 105 indexed citations
11.
Linecker, Michael, Përparim Limani, Patryk Kambakamba, et al.. (2016). Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy. Annals of Surgery. 266(2). 324–332. 12 indexed citations
12.
Sobolewski, Cyril, et al.. (2015). MicroRNAs in Fatty Liver Disease. Seminars in Liver Disease. 35(1). 12–25. 39 indexed citations
13.
Talabot‐Ayer, Dominique, Nicolas Calo, Solenne Vigne, et al.. (2011). The mouseinterleukin (Il)33gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. Journal of Leukocyte Biology. 91(1). 119–125. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026